The stock market spiked notably Monday, following news that a COVID-19 vaccine candidate has shown encouraging trial results. But before you load up on Moderna stock, it might be helpful to keep a couple...
Reformulated booster shots ready by September, White House says
Jul 29, 2022
The Biden administration is working on contracts for the reformulated booster doses.
Risk for progression to severe COVID-19 lower with nirmatrelvir + ritonavir
Mar 01, 2022
Treatment of symptomatic COVID-19 with nirmatrelvir plus ritonavir was linked to an 89% lower risk for progression versus placebo.
Remdesivir offers some benefit for hospitalized COVID-19 patients
Feb 01, 2022
No difference was seen for in-hospital mortality, but a need for initiation of mechanical ventilation was reduced with the addition of remdesivir to standard care.
Incidence rates of SARS-CoV-2 similar for children, adults
Oct 15, 2021
“Children are not only capable of becoming infected, but are also capable of transmitting SARS-CoV-2,” write the authors of an accompanying editorial.
Lawmakers should force private equity firms out of nursing homes, advises one think tank
By
James M. Berklan
May 04, 2021
A “worrisome trend” of private equity investment in nursing homes should be scrutinized and halted altogether within five years, asserts a left-leaning think tank in an issue brief released Friday.
Antibody levels after COVID-19 vaccination inversely linked to body weight
May 23, 2022
An inverse correlation was sustained for up to six months following two doses of BNT162b2 (Pfizer–BioNTech) in a small cohort of healthy young and middle-aged adults.
Nation’s largest nurses union takes aim at CDC over new mask guidance
By
Diane Eastabrook
May 18, 2021
National Nurses United (NNU) slammed the Centers for Disease Control and Prevention (CDC) on its new COVID-19 guidance.
Continue to be careful
By
Lois A. Bowers
Apr 19, 2021
Recent COVID-19 outbreaks among vaccinated residents at senior living communities are a reminder that we all should continue to be careful.
‘Stealth’ version of omicron variant no cause for alarm, experts say
Jan 31, 2022
The new version of the variant does not appear to cause more severe disease, and vaccines are effective against it.